A Science and Technology Blog
According to a preliminary report posted on December 19 by the COG-UK Consortium scientists, as of December 15, 1,623 variant genomes have been sequenced. In a December 21 tweet, COG-UK…
FDA grants emergency use authorisation for convalescent plasma even in the absence of evidence from randomised, controlled trial. Mr. Trump, FDA Commissioner and Secretary of Health and Human Services made…
The immune system elicits robust, broad and highly functional memory T cell responses once a person is infected with novel coronavirus. T cells were found even in the absence of…
The researchers found passive transfer of neutralising antibodies isolated from convalescent plasma into Syrian hamsters protect the animals against the disease when exposed to the virus and also protects hamsters…
ICMR’s insistence on an evidence-based approach to plasma therapy is a welcome change and is in stark contrast to the cavalier manner in which it approved hydroxychloroquine as a prophylaxis…
About 30% of patients with mild symptoms failed to develop high amounts of neutralising antibodies even after recovering from COVID-19 disease. If natural infection with novel coronavirus does not elicit…
A pharma company in China is testing convalescent plasma therapy to treat critically sick COVID-19 patients. So far, 13 patients have been treated and some improvements in clinical symptoms have…
The year 2015 is likely to see some key science developments. The one that most people are eagerly looking forward to is the development of an effective and efficacious Ebola…
